characteristics,trial,arm,mean,sd,type,n
sex_female,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.401041667,NA,categorical,192
sex_male,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.598958333,NA,categorical,192
race_white,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
race_race_other,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
geo_australia_new_zealand,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
geo_europe,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
geo_north_americas,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
geo_other,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
ethnicity_hispanic_latino,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
ethnicity_not_hispanic_latino,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
smoke_current_former_smoker,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
smoke_never_smoked,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
ecog_ecog_0,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.708333333,NA,categorical,192
ecog_ecog_1,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.291666667,NA,categorical,192
ecog_missing,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0,NA,categorical,192
baseline_met_stage_m0,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.046875,NA,categorical,192
baseline_met_stage_m1a,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.135416667,NA,categorical,192
baseline_met_stage_m1b,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.177083333,NA,categorical,192
baseline_met_stage_m1c,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.640625,NA,categorical,192
baseline_met_stage_m1d,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0,NA,categorical,192
baseline_met_stage_m01a,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.182291667,NA,categorical,192
baseline_met_stage_m01a1b,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.359375,NA,categorical,192
baseline_met_stage_m1c1d,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.640625,NA,categorical,192
ldh_cat_ldh_great_uln,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.286458333,NA,categorical,192
ldh_cat_ldh_lower_equal_uln,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.713541667,NA,categorical,192
ldh_cat2_ldh_great_2xuln,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
bmhist_history_of_brain_metastases,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
bmhist_no_history_of_brain_metastases,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
n_disease_sites_n_disease_sites_eql_above_3,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
n_disease_sites_n_disease_sites_below_3,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
n_organs_0,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0,NA,categorical,192
n_organs_1,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.244791667,NA,categorical,192
n_organs_2,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.302083333,NA,categorical,192
n_organs_equal_above_3,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.453125,NA,categorical,192
prior_antineoplastic_not_received,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
prior_antineoplastic_received,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
prior_treatment_anti_ctla4,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
prior_treatment_anti_pd1,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
prior_treatment_combo_anti_ctla4_anti_pd1,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
prior_treatment_combo_braf_mek_nras_inhibitor,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
prior_treatment_interferon,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.265625,NA,categorical,192
prior_treatment_investigational_antineoplastic_agents,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
immunotherapy,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.296875,NA,categorical,192
ORR_bicr,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.635416667,NA,categorical,192
ORR_investigator,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.755208333,NA,categorical,192
age_below_57,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.5,NA,categorical,192
metsite_non_visceral,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
metsite_visceral,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
metsite_visceral_disease_status_not_report,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,NA,NA,categorical,192
AE_any,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.984375,NA,categorical,192
AE_g3,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.682291667,NA,categorical,192
AE_disc,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.104166667,NA,categorical,192
ae_rash,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.161458333,NA,categorical,192
ae_diarrhoea,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.385416667,NA,categorical,192
ae_fatigue,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.296875,NA,categorical,192
ae_arthralgia,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.286458333,NA,categorical,192
ae_pruritus,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.125,NA,categorical,192
TRAE_any,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.984375,NA,categorical,192
TRAE_g3,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.682291667,NA,categorical,192
TRAE_disc,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.104166667,NA,categorical,192
TRAE_rash,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.161458333,NA,categorical,192
TRAE_diarrhoea,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.385416667,NA,categorical,192
TRAE_fatigue,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.296875,NA,categorical,192
TRAE_arthralgia,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.286458333,NA,categorical,192
TRAE_pruritus,COLUMBUS (Dummer et al. 2022),Encorafenib + binimetinib,0.125,NA,categorical,192
